Related Experiment Video
Updated: Oct 14, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
AHA/ACC vs ESC Guidelines for Management of Adults With Congenital Heart Disease: JACC Guideline Comparison
Gabriele Egidy Assenza1, Eric V Krieger2, Helmut Baumgartner3
1Pediatric Cardiology and Adult Congenital Heart Disease Program, Department of Cardio-Thoracic and Vascular Medicine IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Insights
The American Heart Association (AHA) and European Society of Cardiology (ESC) released adult congenital heart disease guidelines in 2018 and 2020, respectively. This review compares their consensus and discrepancies, impacting patient care.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease Management
- Clinical Practice Guidelines
Background:
- Published guidelines for adult congenital heart disease (ACHD) management by the AHA/ACC (2018) and ESC (2020).
- These guidelines offer crucial direction for healthcare professionals treating ACHD patients.
- Variations between guidelines can influence clinical decision-making and patient outcomes.
Purpose of the Study:
- To compare and contrast the 2018 AHA/ACC and 2020 ESC guidelines for ACHD management.
- To identify key areas of agreement and divergence between the two guideline documents.
- To explore potential reasons for discrepancies and their clinical implications.
Main Methods:
- Comparative analysis of the 2018 AHA/ACC and 2020 ESC guidelines.
- Identification of consensus points and areas of disagreement.
- Discussion of the rationale behind differing recommendations.
Main Results:
- Broad consensus exists between the AHA/ACC and ESC guidelines on many aspects of ACHD management.
- Significant differences were identified in specific recommendations, potentially affecting patient care pathways.
- The review highlights areas requiring further clarification or harmonization.
Conclusions:
- While consensus exists, disparities in ACHD guidelines necessitate careful consideration by clinicians.
- Understanding these differences is crucial for optimizing patient management and ensuring consistent care.
- Further dialogue may be needed to reconcile divergent recommendations for ACHD treatment.
Abstract:
The American Heart Association and American College of Cardiology published practice guidelines for the management of adult congenital heart disease in 2018 and the European Society of Cardiology published analogous guidelines in 2020. Although there are broad areas of consensus between the 2 documents, there are important differences that impact patient management. This review discusses key areas of agreement and disagreement between the 2 guidelines, with discussion of possible reasons for disagreement and potential implications.

